Home > 2-Chloro-N,N-dimethylaniline > 2-Chloro-N,N-dimethylaniline(698-01-1)
2-Chloro-N,N-dimethylaniline(698-01-1)
Supplier Product Identification
Physical and Chemical Properties
First Aid Measures
Hazards Identification
Fire Fighting Measures
Product Identification
Product Name
2-Chloro-N,N-dimethylaniline
2-Chloro-N,N-dimethylaniline
Synonyms
o-Chloro-N,N-dimethylaniline
o-Chloro-N,N-dimethylaniline
CAS
698-01-1
698-01-1
Formula
C8H10ClN
C8H10ClN
Molecular Weight
155.62
155.62
Beilstein/Gmelin
2205740
2205740
Beilstein Reference
4-12-00-01116
4-12-00-01116
Physical and Chemical Properties
Solubility in water
Insoluble
Insoluble
Boiling Point
206 - 208
206 - 208
Vapor Pressure
0.23 (25 C)
0.23 (25 C)
Density
1.1067 g/cm3 (20 C)
1.1067 g/cm3 (20 C)
pKa/pKb
9.60 (pKb)
9.60 (pKb)
Heat Of Vaporization
44.4 kJ/mol
44.4 kJ/mol
Refractive Index
1.5472 (20 C)
1.5472 (20 C)
First Aid Measures
Ingestion
Administer charcoal as a slurry (240 mL water/30 g charcoal). Usual dose: 25 to 100 g in adults/adolescents, 25 to 50 g in children (1 to 12 years), and 1 g/kg in infants less than 1 year old Consider gastroc ;avage after ingestion of a potentially life-threatening amount of poison if it can be performed soon after ingestion (generally within 1 hour). Protect airway by placement in Trendelenburg and left lateral decubitus position or by endotracheal intubation. Control any seizures first.
Administer charcoal as a slurry (240 mL water/30 g charcoal). Usual dose: 25 to 100 g in adults/adolescents, 25 to 50 g in children (1 to 12 years), and 1 g/kg in infants less than 1 year old Consider gastroc ;avage after ingestion of a potentially life-threatening amount of poison if it can be performed soon after ingestion (generally within 1 hour). Protect airway by placement in Trendelenburg and left lateral decubitus position or by endotracheal intubation. Control any seizures first.
Inhalation
Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, for respiratory tract irritation bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with inhaled beta2 agonist and oral or parenteral corticosteroids.
Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, for respiratory tract irritation bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with inhaled beta2 agonist and oral or parenteral corticosteroids.
Skin
Skin should be thoroughly washed with soap and water. Contaminated clothing and shoes should be discarded Seek medical attention. Administer 100 percent humidified supplemental oxygen with assisted ventilation as required. Treat for methemoglobinemia and sequelae. Signs and symptoms of methemoglobinemia may be delayed.
Skin should be thoroughly washed with soap and water. Contaminated clothing and shoes should be discarded Seek medical attention. Administer 100 percent humidified supplemental oxygen with assisted ventilation as required. Treat for methemoglobinemia and sequelae. Signs and symptoms of methemoglobinemia may be delayed.
Eyes
Irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.
Irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.
Hazards Identification
Ingestion
Nausea and vomiting may occur. Metabolic acidosis may develop secondary to tissue hypoxia.
Nausea and vomiting may occur. Metabolic acidosis may develop secondary to tissue hypoxia.
Inhalation
Dyspnea and tachypnea may occur. CNS effects include headache, dizziness, altered mental status, confusion, lethargy progressing to coma seizures and syncope; these occur secondary to CNS hypoxia, usually with levels > 20 percent.
Dyspnea and tachypnea may occur. CNS effects include headache, dizziness, altered mental status, confusion, lethargy progressing to coma seizures and syncope; these occur secondary to CNS hypoxia, usually with levels > 20 percent.
Skin
Central cyanosis unresponsive to oxygen therapy is classic.
Central cyanosis unresponsive to oxygen therapy is classic.
Eyes
Causes severe irritation.
Causes severe irritation.
Fire Fighting Measures
Flash Point
74
74
Contact
More
- Company Name:Creasyn Finechem(Tianjin) Co., Ltd.
- Tel:022-83946278 13820503911
- Fax:022-83945176
- WebSite:http://www.creasyn.com/
- Company Name:J & K SCIENTIFIC LTD.
- Tel:010-82848833 400-666-7788
- Fax:86-10-82849933
- WebSite:http://www.jkchemical.com
- Company Name:ShangHai DEMO Chemical Co.,Ltd
- Tel:400-021-7337 2355568890
- Fax:0086-21-50182339
- WebSite:http://www.demochem.com
- Company Name:Energy Chemical
- Tel:021-021-58432009 400-005-6266
- Fax:021-58436166
- WebSite:http://www.energy-chemical.com
- Company Name:Capot Chemical Co., Ltd
- Tel:+86 (0) 571 85 58 67 18
- Fax:0086-571-85864795
- WebSite:http://www.capotchem.com/